icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
micardis
boehringer ingelheim international gmbh - telmisartan - hypertensjon - angiotensin ii antagonister, vanlig - hypertensiontreatment av essensiell hypertensjon hos voksne. kretsløpssystem preventionreduction av hjerte-sykdom hos pasienter med manifest atherothrombotic hjerte-og karsykdommer (history of coronary hjertesykdommer, hjerneslag, eller perifer arteriell sykdom) eller;type-2 diabetes mellitus med dokumentert mål-organskade.
micardis 40 mg
farmagon - telmisartan - tablett - 40 mg
micardis 80 mg
farmagon - telmisartan - tablett - 80 mg
micardis 40 mg
orifarm as - telmisartan - tablett - 40 mg
micardis 80 mg
orifarm as - telmisartan - tablett - 80 mg
micardis 80 mg
2care4 aps - telmisartan - tablett - 80 mg
micardisplus 80 mg / 12.5 mg
2care4 aps - telmisartan / hydroklortiazid - tablett - 80 mg / 12.5 mg
micardisplus 80 mg / 12.5 mg
farmagon - telmisartan / hydroklortiazid - tablett - 80 mg / 12.5 mg
micardisplus 80 mg / 25 mg
2care4 aps - telmisartan / hydroklortiazid - tablett - 80 mg / 25 mg